A detailed history of Charles Schwab Investment Management Inc transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 944,282 shares of IART stock, worth $20.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
944,282
Previous 818,662 15.34%
Holding current value
$20.9 Million
Previous $23.9 Million 28.08%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.14 - $31.74 $2.15 Million - $3.99 Million
125,620 Added 15.34%
944,282 $17.2 Million
Q2 2024

Aug 12, 2024

BUY
$23.14 - $34.72 $5.12 Million - $7.68 Million
221,078 Added 37.0%
818,662 $23.9 Million
Q1 2024

May 08, 2024

BUY
$33.4 - $45.2 $1.14 Million - $1.54 Million
33,983 Added 6.03%
597,584 $21.2 Million
Q4 2023

Feb 06, 2024

BUY
$34.21 - $44.59 $611,093 - $796,511
17,863 Added 3.27%
563,601 $24.5 Million
Q3 2023

Nov 08, 2023

SELL
$37.8 - $45.97 $5.92 Million - $7.2 Million
-156,702 Reduced 22.31%
545,738 $20.8 Million
Q2 2023

Aug 09, 2023

SELL
$37.95 - $58.98 $3.35 Million - $5.21 Million
-88,275 Reduced 11.16%
702,440 $28.9 Million
Q1 2023

May 11, 2023

BUY
$52.61 - $60.49 $2.67 Million - $3.07 Million
50,747 Added 6.86%
790,715 $45.4 Million
Q4 2022

Feb 13, 2023

BUY
$42.17 - $58.6 $3 Million - $4.17 Million
71,125 Added 10.63%
739,968 $41.5 Million
Q3 2022

Nov 14, 2022

BUY
$42.28 - $57.17 $413,371 - $558,951
9,777 Added 1.48%
668,843 $28.3 Million
Q2 2022

Aug 15, 2022

BUY
$53.86 - $66.52 $7,432 - $9,179
138 Added 0.02%
659,066 $35.6 Million
Q1 2022

May 13, 2022

BUY
$62.86 - $69.24 $1.49 Million - $1.64 Million
23,751 Added 3.74%
658,928 $42.3 Million
Q4 2021

Feb 11, 2022

BUY
$62.47 - $73.25 $1.16 Million - $1.36 Million
18,554 Added 3.01%
635,177 $42.6 Million
Q3 2021

Nov 16, 2021

BUY
$64.97 - $76.19 $1.96 Million - $2.3 Million
30,154 Added 5.14%
616,623 $42.2 Million
Q2 2021

Aug 16, 2021

BUY
$66.79 - $76.63 $1.33 Million - $1.52 Million
19,848 Added 3.5%
586,469 $40 Million
Q1 2021

May 17, 2021

BUY
$62.63 - $71.15 $896,673 - $1.02 Million
14,317 Added 2.59%
566,621 $39.1 Million
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $51,798 - $79,593
-1,196 Reduced 0.22%
552,304 $35.9 Million
Q3 2020

Nov 13, 2020

BUY
$43.33 - $51.72 $5,156 - $6,154
119 Added 0.02%
553,500 $26.1 Million
Q2 2020

Aug 14, 2020

BUY
$41.42 - $55.57 $1,366 - $1,833
33 Added 0.01%
553,381 $26 Million
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $88,521 - $147,350
2,414 Added 0.44%
553,348 $24.7 Million
Q4 2019

Feb 07, 2020

BUY
$55.73 - $62.49 $373,613 - $418,932
6,704 Added 1.23%
550,934 $32.1 Million
Q3 2019

Nov 08, 2019

BUY
$53.29 - $64.59 $2.91 Million - $3.53 Million
54,640 Added 11.16%
544,230 $32.7 Million
Q2 2019

Aug 09, 2019

BUY
$46.45 - $55.85 $612,768 - $736,773
13,192 Added 2.77%
489,590 $27.3 Million
Q1 2019

May 14, 2019

BUY
$42.97 - $57.33 $1.4 Million - $1.87 Million
32,598 Added 7.35%
476,398 $26.5 Million
Q4 2018

Feb 14, 2019

BUY
$42.62 - $64.51 $43,600 - $65,993
1,023 Added 0.23%
443,800 $20 Million
Q3 2018

Nov 13, 2018

BUY
$57.63 - $65.87 $8.04 Million - $9.19 Million
139,546 Added 46.02%
442,777 $29.2 Million
Q2 2018

Aug 08, 2018

SELL
$54.05 - $67.23 $3.46 Million - $4.3 Million
-64,021 Reduced 17.43%
303,231 $19.5 Million
Q1 2018

May 07, 2018

BUY
$46.55 - $57.38 $2.03 Million - $2.5 Million
43,642 Added 13.49%
367,252 $20.3 Million
Q4 2017

Jan 17, 2018

BUY
$46.22 - $51.77 $1.38 Million - $1.54 Million
29,836 Added 10.16%
323,610 $15.5 Million
Q3 2017

Nov 13, 2017

BUY
$47.8 - $53.63 $14 Million - $15.8 Million
293,774
293,774 $14.8 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.